Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma

Tohoku Journal of Experimental Medicine

Volumn 224, Issue 1, 2011, Pages 29-39

  Liu, Wenbin ^a   Xu, Geliang ^a   Ma, Jinliang ^a   Jia, Weidong ^a   Li, Jiansheng ^a   Chen, Ke ^a   Wang, Wei ^a   Hao, Chen ^a   Wang, Yongcang ^a   Wang, Xiujun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Matrix metalloproteinase; Osteopontin; Plasminogen activator; Vasculogenic mimicry

Indexed keywords

GELATINASE A; GELATINASE B; OSTEOPONTIN; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; VASCULOGENIC MIMICRY;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 79955496817     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.224.29     Document Type: Article

References (40)

1. Baeten, C.I., Hillen, F., Pauwels, P., de Bruine, A.P. & Baeten, C.G. (2009) Prognostic role of vasculogenic mimicry in colorectal cancer. Dis. Colon Rectum, 52, 2028-2035.
2. Basu, G.D., Liang, W.S., Stephan, D.A., Wegener, L.T., Conley, C.R., Pockaj, B.A. & Mukherjee, P. (2006) A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res., 8, R69.
3. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., Sampas, N., Dougherty, E., Wang, E., Marincola, F., Gooden, C., Lueders, J., Glatfelter, A., Pollock, P., Carpten, J., Gillanders, E., Leja, D., Dietrich, K., Beaudry, C., Berens, M., Alberts, D. & Sondak, V. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406, 536-540.
4. Briese, J., Cheng, S., Ezzat, S., Liu, W., Winer, D., Wagener, C., Bamberger, A.M. & Asa, S.L. (2010) Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res., 30, 1681-1688.
5. Caruso, D.J., Carmack, A.J., Lokeshwar, V.B., Duncan, R.C., Soloway, M.S. & Lokeshwar, B.L. (2008) Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin. Cancer Res., 14, 4111-4118.
6. Chan, C.F., Yau, T.O., Jin, D.Y., Wong, C.M., Fan, S.T. & Ng, I.O. (2004) Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological signifcance in hepatocellular carcinoma. Clin. Cancer Res., 10, 4140-4149.
7. Chang, Y.S., di Tomaso, E., McDonald, D.M., Jones, R., Jain, R.K. & Munn, L.L. (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with fowing blood. Proc. Natl. Acad. Sci. USA, 97, 14608-14613.
8. Chen, R., Crispin, D.A., Pan, S., Hawley, S., McIntosh, M.W., May, D., Anton-Culver, H., Ziogas, A., Bronner, M.P. & Brentnall, T.A. (2010) Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas, 39, 981-988.
9. Chen, R.X., Xia, Y.H., Xue, T.C. & Ye, S.L. (2010) Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression. Mol. Biol. Rep. [Epub ahead of print]
10. Cho, H., Hong, S.W., Oh, Y.J., Kim, M.A., Kang, E.S., Lee, J.M., Kim, S.W., Kim S.H., Kim, J.H., Kim, Y.T. & Lee, K. (2008) Clinical significance of osteopontin expression in cervical cancer. J. Cancer Res. Clin. Oncol., 134, 909-917.
11. Fan, Y.Z., Sun, W., Zhang, W.Z. & Ge, C.Y. (2007) [Vasculogenic mimicry in human primary gallbladder carcinoma and clinical signifcance thereof]. Zhonghua Yi Xue Za Zhi, 87, 145-149.
12. Folberg, R. & Maniotis, A.J. (2004) Vasculogenic mimicry. APMIS, 112, 508-525.
13. Folkman, J. (1996) Fighting cancer by attacking its blood supply. Sci. Am., 275, 150-154.
14. Folkman, J. & Klagsbrun, M. (1987) Angiogenic factors. Science, 235, 442-447.
15. Guzman, G., Cotler, S.J., Lin, A.Y., Maniotis, A.J. & Folberg, R. (2007) A pilot study of vasculogenic mimicry immunohisto-chemical expression in hepatocellular carcinoma. Arch. Pathol. Lab. Med., 131, 1776-1781.
16. Hendrix, M.J., Seftor, E.A., Hess, A.R. & Seftor, R.E. (2003) Molecular plasticity of human melanoma cells. Oncogene, 22, 3070-3075.
17. Hendrix, M.J., Seftor, E.A., Meltzer, P.S., Gardner, L.M., Hess, A.R., Kirschmann, D.A., Schatteman, G.C. & Seftor, R.E. (2001) Expression and functional signifcance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl. Acad. Sci. USA, 98, 8018-8023.
18. Heyman, L., Leroy-Dudal, J., Fernandes, J., Seyer, D., Dutoit, S. & Carreiras, F. (2010) Mesothelial vitronectin stimulates migration of ovarian cancer cells. Cell Biol. Int., 34, 493-502.
19. Huang, H., Zhang, X.F., Zhou, H.J., Xue, Y.H., Dong, Q.Z., Ye, Q.H. & Qin, L.X. (2010) Expression and prognostic signif-cance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection. Cancer Sci., 101, 1314-1319.
20. Imano, M., Satou, T., Itoh, T., Sakai, K., Ishimaru, E., Yasuda, A., Peng, Y.F., Shinkai, M., Akai, F., Yasuda, T., Imamoto, H., Okuno, K., Ito, H., Shiozaki, H. & Ohyanagi, H. (2009) Immunohistochemical expression of osteopontin in gastric cancer. J. Gastrointest. Surg., 13(9), 1577-1582.
21. Jain, R.K. (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science, 307, 58-62.
22. Kadkol, S.S., Lin, A.Y., Barak, V., Kalickman, I., Leach, L., Valyi-Nagy, K., Majumdar, D., Setty, S., Maniotis, A.J., Folberg, R. & Pe'er, J. (2006) Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Invest. Ophthalmol. Vis. Sci., 47, 802-806.
23. Kato, N. & Motoyama, T. (2008) Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression. Histopathology, 52, 682-688.
24. Kim, S.H., Chung, Y.H., Yang, S.H., Kim, J.A., Jang, M.K., Kim, S.E., Lee, D., Lee, S.H., Kim, K.M., Lim, Y.S., Lee, H.C., Lee, Y.S. & Suh, D.J. (2009) Prognostic value of serum osteo-pontin in hepatocellular carcinoma patients treated with trans-arterial chemoembolization. Korean J. Hepatol., 15, 320-330.
25. Likui, W., Hong, W. & Shuwen, Z. (2010) Clinical signifcance of the upregulated osteopontin mRNA expression in human colorectal cancer. J. Gastrointest. Surg., 14, 74-81.
26. Liu, W.B., Xu, G.L., Jia, W.D., Li, J.S., Ma, J.L., Chen, K., Wang, Z.H., Ge, Y.S., Ren, W.H., Yu, J.H., Wang, W. & Wang, X.J. (2010) Prognostic signifcance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Med Oncol. doi: 10.1007/s12032-010-9706-x
27. Macri, A., Versaci, A., Lupo, G., Trimarchi, G., Tomasello, C., Loddo, S., Sfuncia, G., Caminiti, R., Teti, D. & Famulari, C. (2009) Role of osteopontin in breast cancer patients. Tumori, 95, 48-52.
28. Maniotis, A.J., Folberg, R., Hess, A., Seftor, E.A., Gardner, L.M., Pe'er, J., Trent, J.M., Meltzer, P.S. & Hendrix, M.J. (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol., 155, 739-752.
29. Mirshahi, P., Rafii, A., Vincent, L., Berthaut, A., Varin, R., Kalantar, G., Marzac, C., Calandini, O.A., Marie, J.P., Soria, C., Soria, J. & Mirshahi, M. (2009) Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia, 23, 1039-1048.
30. Semela, D. & Dufour, J.F. (2004) Angiogenesis and hepatocellular carcinoma. J. Hepatol., 41, 864-880.
31. Shevde, L.A., Metge, B.J., Mitra, A., Xi, Y., Ju, J., King, J.A. & Samant, R.S. (2010) Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin. J. Cell. Mol. Med., 14, 1693-1706.
32. Sood, A.K., Seftor, E.A., Fletcher, M.S., Gardner, L.M., Heidger, P.M., Buller, R.E., Seftor, R.E. & Hendrix, M.J. (2001) Molecular determinants of ovarian cancer plasticity. Am. J. Pathol., 158, 1279-1288.
33. Sun, B., Zhang, S., Zhang, D., du, J., Guo, H., Zhao, X., Zhang, W. & Hao, X. (2006) Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol. Rep., 16, 693-698.
34. Sun, T., Zhao, N., Zhao, X.L., Gu, Q., Zhang, S.W., Che, N., Wang, X.H., Du, J., Liu, Y.X. & Sun, B.C. (2010) Expression and functional signifcance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology, 51, 545-556.
35. Theret, N., Musso, O., Turlin, B., Lotrian, D., Bioulac-Sage, P., Campion, J.P., Boudjema, K. & Clement, B. (2001) Increased extra cellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas. Hepatology, 34, 82-88.
36. van der Schaft, D.W., Hillen, F., Pauwels, P., Kirschmann, D.A., Castermans, K., Egbrink, M.G., Tran, M.G., Sciot, R., Hauben, E., Hogendoorn, P.C., Delattre, O., Maxwell, P.H., Hendrix, M.J. & Griffoen, A.W. (2005) Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res., 65, 11520-11528.
37. Vartanian, A.A., Stepanova, E.V., Gutorov, S.L., Solomko, E., Grigorieva, I.N., Sokolova, I.N., Baryshnikov, A.Y. & Lichinitser, M.R. (2009) Prognostic signifcance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. Can. J. Urol., 16, 4726-4732.
38. Wai, P.Y. & Kuo, P.C. (2004) The role of Osteopontin in tumor metastasis. J. Surg. Res., 121, 228-241.
39. Xue, Y.H., Zhang, X.F., Dong, Q.Z., Sun, J., Dai, C., Zhou, H.J., Ren, N., Jia, H.L., Ye, Q.H. & Qin, L.X. (2010) Thrombin is a therapeutic target for metastatic osteopontin-positive hepato-cellular carcinoma. Hepatology, 52, 2012-2022.
40. Zhang, L., Hou, X., Lu, S., Rao, H., Hou, J., Luo, R., Huang, H., Zhao, H., Jian, H., Chen, Z., Liao, M. & Wang, X. (2010) Predictive significance of bone sialoprotein and osteopontin for bone metastases in respected Chinese non-small-cell lung cancer patients: a large cohort retrospective study. Lung Cancer, 67, 114-119.